-
Postdoctoral Research Assistant in Design for Behaviour Change: Circular Economy for Medical Devices
the underlying drivers and barriers that influence stakeholder behaviour and attitudes to return, reuse and remanufacturing of injection devices. 3. Co-designing solutions for the return, reuse and
-
. Find out more about the Lanyon-Hogg group’s research at: https://www.pharm.ox.ac.uk/research/lanyon-hogg-group You should have: Experience in design, synthesis, characterisation of small molecule
-
hold, or are close to completing, a PhD in robotics, robot learning, or a closely related field. You possess strong expertise in deep learning and robot navigation, with hands-on experience in deploying
-
experience in stem cell biology. You should have an extensive hands-on experience in culturing human iPSCs and iPSC-derived cellular models as well as experience with molecular cloning and generating knockout
-
design and have the opportunity to demonstrate its performance by studying key catalytic reactions important to the energy transition. Previous experience of adapting/developing vacuum instrumentation and
-
with a PhD in Engineering (or close to completion) may apply. You will be responsible for: Design of the first reconfigurable robotic matter in collaboration with world-leading universities and
-
specialist knowledge in mechatronics design and control, and proven programming experience in Python, MATLAB or C/C++. Informal enquiries may be addressed to Professor Liang He (email: liang.he@eng.ox.ac.uk
-
, as the “brains” of an agent. We aim to revisit the question of agent design, where LLMs provide NLP interfaces and reasoning capabilities for agents. Our work will be informed by four decades of agent
-
methodology, theory, and applications across the areas of Bayesian experimental design, active learning, probabilistic deep learning, and related topics. The £1.23M project is funded by the UKRI Horizon
-
precancers and developing targeted interventions, including vaccines, to intercept them. The project focuses on designing, validating, and preclinically testing neoepitope-based mRNA vaccines to prevent BRCA